Posts Tagged Cytokinetics

Cytokinetics lung cancer trial fails

San Francisco Business Times - 2:51 PM PST Thursday

Cytokinetics Inc. said Thursday that a clinical trial of ispinesib, an experimental lung cancer treatment, failed.

The South San Francisco drug company (NASDAQ: CYTK) said the Phase II trial, run by GlaxoSmithKline, failed to meet the criteria to advance to the next stage of clinical testing.

More →